Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2023-07-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of Evidence-based Psychotherapy for PTSD
NCT01861769
Comparing Virtual Reality Exposure Therapy to Prolonged Exposure
NCT01459705
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
NCT00656344
Psychosocial Factors and Efficacy of Remote Cognitive Remediation for Post-Traumatic Stress Disorder
NCT07309302
CBT With VR Based Exposure for Social Anxiety Disorder
NCT03973541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VR-CBT
A trained psychotherapist provides CBT-VR for up to 10 sessions over 10 weeks.
VR-CBT
The therapy is focused on emotion regulation through guided learning in virtual reality. The manual is a modified conventional cognitive behavioral therapy to include these aspects and the suggestions of an advisory committee of Inuit and non-Inuit health service providers (e.g., cultural adaptation).
Self-management
Participants use a commercial VR application at home for guided self-management at their own pace over 10 weeks.
Self-management
The previously developed commercial VR program involves guided relaxation and meditation techniques.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR-CBT
The therapy is focused on emotion regulation through guided learning in virtual reality. The manual is a modified conventional cognitive behavioral therapy to include these aspects and the suggestions of an advisory committee of Inuit and non-Inuit health service providers (e.g., cultural adaptation).
Self-management
The previously developed commercial VR program involves guided relaxation and meditation techniques.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Live in Montreal
3. be between 14 to 60 years of age
4. be proficient in English or French
5. No history of cardiac conditions
6. No history of epilepsy
7. Can provide an emergency contact
8. Tolerance of VR headset
9. Tolerance of sensors
10. Has no current suicidal or homicidal risk
11. No history of psychosis or schizophrenia
12. Current stable mood
13. Is generally mentally stable
14. Score less than 8 on the Alcohol Use Disorders Identification Test C
15. Score less than 3 on the Drug Abuse Screen Test (10 item version)
16. Not have had any change in psychoactive medications during 4 weeks preceding screening and inclusion to the study
Exclusion Criteria
2. youth below the age of 14 and adults above the age of 60.
3. self-reported history of psychosis or schizophrenia
4. current substance abuse, as measured by two screens (AUDIT-C, DAST-10)
5. other mental or physical condition that might preclude them from the trial (i.e., pre-existing heart conditions, convulsions, acute mental health risk).
14 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Natural Sciences and Engineering Research Council, Canada
OTHER
MedTeq
INDUSTRY
Douglas Foundation
UNKNOWN
McGill University
OTHER
Douglas Mental Health University Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin Lepage
James McGill professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Outi Linnaranta, MD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Douglas Mental Health University Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Douglas Mental Health University Institute
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IUSMD 21-52
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.